infect
upper
gastrointestin
tract
common
mouth
often
initi
site
exposur
environment
agent
frequent
infecti
manifest
interact
gastroenter
gastrointestin
infect
occur
commonli
infant
young
children
frequent
sampl
environ
via
oral
rout
children
limit
access
clean
water
may
develop
sever
dehydr
though
typic
mild
selflimit
diseas
develop
world
respons
three
million
death
worldwid
usa
gastroenter
associ
half
million
outpati
visit
death
annual
gastroenter
ge
selflimit
inflammatori
disord
stomach
small
intestin
usual
character
combin
abdomin
pain
diarrhea
nausea
vomit
often
label
stomach
flu
may
caus
host
microb
toxin
commonli
due
viral
infect
epidemiolog
infect
differ
age
immun
statu
season
exposur
develop
world
virus
primari
pathogen
account
infecti
diarrhea
viral
gastroenter
vge
trigger
mani
virus
often
norovirus
rotaviru
enter
adenovirus
rotaviru
enter
adenovirus
caliciviru
astroviru
often
associ
diarrheal
ill
infant
young
children
noroviru
ge
often
occur
explos
outbreak
amongst
freeliv
institution
adult
may
spread
person
person
via
vehicl
food
water
tabl
exposur
children
virus
increas
daycar
set
area
poor
sanit
highli
infecti
transmit
via
fecalor
rout
winter
vomit
diseas
first
describ
zahorski
norovirus
norwalklik
virus
later
identifi
caus
ill
name
diarrhea
outbreak
amongst
elementari
school
student
norwalk
ohio
adler
zickl
norovirus
nv
first
viral
agent
proven
caus
ge
part
caliciviru
famili
calicivirus
singl
strand
nm
nonenvelop
rna
virus
includ
norovirus
nm
sapovirus
low
inoculum
need
transmiss
prolong
viral
shed
abil
surviv
environ
norovirus
becom
major
pathogen
account
ge
worldwid
recogn
lead
caus
foodborn
ill
unit
state
cdc
estim
nv
caus
million
ill
hospit
death
cdc
nd
gii
strain
nv
common
outbreak
nv
frequent
report
cruis
ship
nurs
home
school
work
place
outbreak
often
occur
wintertim
henc
monik
winter
vomit
diseas
howev
ill
occur
throughout
year
impact
older
children
adult
nv
ge
short
incub
period
ip
h
typic
caus
acut
onset
nausea
vomit
diarrhea
last
h
howev
viral
shed
prolong
week
even
asymptomat
person
robilotti
et
al
children
chronic
immun
suppress
person
may
experi
prolong
diarrhea
two
challeng
nv
set
cruis
ship
outbreak
often
lead
termin
cruis
healthcar
relat
outbreak
commonli
lead
hospit
unit
closur
zingg
et
al
often
difficult
control
requir
aggress
frequent
environment
clean
bleach
base
solut
strict
soap
water
hand
hygien
nv
inactiv
alcohol
base
hand
sanit
factor
contribut
explos
natur
outbreak
includ
close
contact
restrict
set
high
infect
nv
nv
environment
persist
prolong
viral
shed
lack
longliv
host
immun
worldwid
nv
outbreak
past
decad
associ
emerg
strain
nv
lindesmith
et
al
anoth
caus
agent
vge
caliciviru
famili
singl
strand
nonenvelop
rna
virus
sapoviru
sv
first
identifi
subsequ
name
orphanag
outbreak
diarrhea
sapporo
japan
oka
et
al
sv
differenti
ge
virus
star
david
appear
electron
microscopi
howev
today
identifi
molecular
diagnost
test
use
revers
transcriptasepcr
assay
similar
nv
sapoviru
outbreak
occur
throughout
year
amongst
age
often
foodborn
clinic
manifest
sv
indistinguish
nv
third
especi
import
caus
vge
infant
rotavirus
rotavirus
rv
nm
nonenvelop
doubl
strand
rna
virus
famili
reovirida
genom
consist
segment
code
structur
nonstructur
protein
nsp
viru
made
concentr
shell
outer
protein
protein
inner
capsid
core
p
g
protein
defin
specif
serotyp
induc
protect
neutral
antibodi
blacklow
greenberg
electron
microscopi
rotaviru
appear
welldefin
central
core
radiat
spoke
henc
name
rota
wheellik
viru
rv
classifi
group
af
base
serotyp
base
protein
group
virus
common
group
caus
human
diseas
though
least
differ
serotyp
vge
due
serotyp
rotavirus
extrem
stabl
environ
elimin
hand
wash
rv
first
identifi
duoden
biopsi
children
diarrhea
found
throughout
world
common
caus
sever
diarrhea
amongst
infant
young
children
unit
state
rotaviru
vaccin
introduc
prior
rotaviru
vaccin
nearli
us
children
infect
rotaviru
age
account
signific
morbid
excess
er
visit
hospit
annual
death
rotaviru
nd
worldwid
rv
remain
common
vge
affect
children
peak
incid
rv
month
matern
antibodi
level
protect
may
wane
infant
impact
age
similar
nv
rv
shed
high
concentr
stool
easili
transmit
within
household
prior
introduc
rv
vaccin
usa
rv
season
peak
winter
novemberapril
vaccin
era
rv
ge
becom
sporad
rotaviru
infect
asymptomat
symptomat
incub
period
day
ill
last
day
though
typic
associ
young
children
immunocompromis
adult
elderli
travel
care
children
rv
ge
risk
ill
less
common
virus
associ
vge
astrovirus
adenovirus
rare
coronavirus
astrovirus
famili
astrovirida
small
nm
nonenvelop
singl
strand
rna
virus
caus
around
viral
ge
children
often
found
commun
health
facil
bosch
et
al
virus
first
identifi
human
preval
eight
serotyp
type
viral
ge
due
usual
mild
requir
hospit
nm
five
six
point
star
appear
electron
microscopi
identifi
primarili
multiplex
molecular
diagnost
test
stool
sampl
human
adenovirus
hadv
nm
nonenvelop
doublestrand
dna
virus
caus
mani
human
ill
best
known
respiratori
ocular
infect
howev
adenovirus
primarili
adenoviru
serotyp
caus
viral
ge
children
two
lion
unlik
rv
adv
ge
display
season
incub
period
ill
adv
longer
rv
nv
day
ill
typic
last
day
also
often
identifi
use
multiplex
pcr
diagnost
test
stool
despit
frequenc
pathophysiolog
vge
syndrom
poorli
understood
ingest
oral
target
differ
cell
within
upper
gastrointestin
tract
recent
discoveri
use
enteroid
murin
model
nv
advanc
understand
virus
interact
mammalian
host
factor
import
nv
pathogenesi
includ
attach
hbga
tissu
cellular
tropism
viru
host
immun
respons
host
gut
microbiota
degraaf
et
al
murin
model
nv
appear
infect
enterocyt
immun
cell
infect
enterocyt
shown
human
appear
nv
target
human
immun
cell
includ
macrophag
dendrit
cell
b
tcell
murin
nv
transcytos
across
intestin
epitheli
cell
cultur
via
microfold
cell
without
product
infect
disrupt
tight
junction
gonzalezhernandez
et
al
cell
special
intestin
epitheli
cell
gutassoci
lymphoid
tissu
sampl
particul
antigen
lumen
host
deliv
underli
immun
cell
nv
exploit
pathway
pass
intestin
epithelium
reach
immun
target
cell
without
harm
enterocyt
htype
histoblood
group
antigen
hbga
glycan
express
surfac
specif
cell
present
saliva
bodili
secret
determin
abo
lewi
blood
group
certain
cell
type
fucosyltransferas
also
known
galactosid
add
fucos
group
precursor
hbga
gener
variou
hbga
degraaf
et
al
bind
specif
noroviru
differ
hbga
vari
noroviru
genotyp
determin
suscept
specif
nv
strain
nonsecretor
lack
less
suscept
nv
infect
gi
gii
strainscommens
gut
bacteria
express
hbga
also
play
role
bcell
infect
nv
karst
antimicrobi
treatment
gut
microbiota
mice
reduc
nv
replic
jone
et
al
replet
restor
nv
infect
addit
commens
gut
bacteria
suppress
antivir
activ
type
iii
interferon
allow
persist
nv
within
colon
baldridg
et
al
mechan
may
allow
persist
prolong
viral
shed
mechan
nv
induc
vomit
may
due
delay
empti
abnorm
gastric
motor
function
though
known
rotavirus
pathogenesi
complex
incomplet
understood
diarrhea
believ
multifactori
due
malabsorpt
rotaviru
enterotoxin
secret
trigger
activ
enter
nervou
system
rv
particl
ingest
trypsin
cleav
spike
protein
two
termin
fragment
contain
hemagglutinin
domain
wherea
betabarrel
domain
interact
membran
small
intestin
enterocyt
interact
mediat
via
interact
sialic
acidcontain
nonsialyl
receptor
molecul
hbga
rv
intern
outer
capsid
lost
activ
virionassoci
transcriptas
viral
macromolecular
synthas
viral
protein
rna
concentr
cytoplasm
structur
call
viroplasm
rna
replic
packag
take
place
intracellular
event
probabl
involv
nonstructur
protein
rv
enterotoxin
trigger
releas
ca
endoplasm
reticulum
lundgren
svensson
viroporin
domain
calciumconduct
ion
channel
increas
intracellular
ca
concentr
begin
cascad
cellular
process
includ
disrupt
microvillar
cytoskelet
network
lower
express
disaccharidas
enzym
apic
surfac
gener
inhibit
na
solut
cotransport
system
necrosi
appear
releas
specif
ca
depend
nonclass
secret
pathway
prior
cell
lysi
event
lead
malabsorpt
compon
diarrhea
reduct
absorpt
capac
epithelium
reduc
activ
na
solut
cotransport
reduct
digest
enzym
express
epitheli
surfac
hagborn
et
al
develop
serum
mucos
antibodi
may
protect
diseas
en
also
play
role
rv
diseas
inhibit
serotonin
receptor
enkephalinas
may
reduc
secretori
compon
diarrhea
addit
en
may
associ
hypermotil
vomit
via
nitric
oxid
pathway
immun
respons
rv
involv
innat
cellular
humor
immun
episod
asymptomat
rv
may
provid
partial
protect
reduc
likelihood
sever
symptomat
infect
singl
episod
rotaviru
infect
inadequ
gener
perman
immun
durat
protect
shortliv
repeat
asymptomat
infect
may
help
maintain
long
stand
immun
thirtyeight
percent
children
protect
first
natur
episod
infect
protect
diarrhea
sever
diseas
repeat
exposur
lead
protect
rotaviru
diarrhea
clearli
multicompon
diseas
evid
exist
malabsorpt
secretori
compon
mediat
diseas
compon
rang
primari
cellular
damag
secret
viral
enterotox
peptid
virusinduc
interact
enter
nervou
system
en
malabsorpt
compon
rotaviru
diarrhea
appear
relat
primari
infect
viru
secretori
compon
rotaviru
diarrhea
appear
secondari
virusinduc
function
chang
villu
epithelium
central
player
secret
appear
en
viral
ge
manifest
acut
onset
diarrhea
often
accompani
nausea
vomit
fever
abdomin
pain
rapid
onset
vomit
may
help
differenti
bacteri
protozo
mediat
diarrheal
diseas
viral
ge
associ
bloodi
diarrhea
though
certain
symptom
pattern
may
seen
typic
specif
virus
differenti
basi
symptom
alon
primarili
diseas
adult
nv
tend
explos
short
incub
period
symptom
day
nausea
vomit
promin
earli
symptom
follow
wateri
diarrhea
cramp
headach
fever
malais
immunocompromis
host
ill
prolong
sever
excret
viru
month
primarili
diseas
young
children
infant
fever
fahrenheit
vomit
nausea
preced
onset
wateri
diarrhea
unlik
nv
usual
short
live
rv
diarrhea
persist
day
main
contributor
mortal
astrovirus
may
impact
infant
adult
especi
immunosuppress
like
nv
incub
short
day
follow
wateri
diarrhea
cramp
headach
low
grade
fever
last
day
vomit
less
often
seen
adenoviru
gastroenter
often
children
immunocompromis
host
incub
period
prolong
rna
virus
diarrhea
may
prolong
last
day
diagnosi
vge
often
genericthat
viral
gastroenter
epidemiolog
clinic
featur
may
point
specif
viral
etiolog
sampl
may
collect
identifi
set
clinic
guidelin
recommend
diagnost
test
selflimit
ge
episod
hane
et
al
era
rapid
nucleic
acid
test
diagnost
test
differenti
princip
done
epidemiolog
purpos
howev
stool
test
done
alarm
symptomssign
sever
dehydr
renal
electrolyt
dysfunct
sever
abdomin
pain
symptom
week
age
immunocompromis
pregnant
bloodi
stool
outbreak
widespread
use
antigen
molecular
diagnost
mani
identifi
specif
stool
antigen
test
avail
identifi
rotaviru
norovirus
rotaviru
stool
eia
antigen
wide
avail
multiplex
pcr
test
stool
sampl
rapidli
identifi
bacteri
viral
protozoa
associ
diarrheal
ill
medic
therapi
necessari
major
patient
nonsever
viral
ge
import
aspect
treatment
acut
viral
ge
hydrat
electrolyt
replet
oral
rehydr
solut
or
balanc
sodiumglucos
solut
dramat
reduc
mortal
infecti
diarrhea
develop
world
diarrhea
slow
use
antidiarrh
drug
either
slow
secret
motil
recent
studi
suggest
may
benefit
use
ondansetron
reduc
upper
lower
gastrointestin
symptom
children
vge
antisecretori
agent
bismuth
subsalicyl
bss
peptobismol
crofelem
mytesi
formerli
fulyzaq
may
effect
secretori
diarrhea
crofelem
cystic
fibrosi
transmembran
regul
chloridechannel
blocker
shown
use
travel
diarrhea
hivassoci
diarrhea
recommend
dose
bss
ml
mg
liquid
two
tablet
mg
per
tablet
chew
min
exceed
eight
dose
h
crofelem
administ
mg
delay
releas
tablet
taken
twice
daili
two
antimotil
drug
use
acut
diarrhea
loperamid
imodium
diphenoxylateatropin
lomotil
loperamid
activ
two
work
inhibit
segment
contract
gut
slow
intralumin
fluid
movement
allow
greater
absorpt
loperamid
dose
mg
initi
follow
mg
loos
stool
mgday
adult
lomotil
dose
mg
tab
time
daili
agent
use
diarrhea
includ
adsorb
kaolin
pectin
charcoal
attapulgit
help
form
stool
number
stool
durat
diarrhea
shorten
effect
way
prevent
viral
ge
wash
hand
regularli
least
alway
done
chang
diaper
use
bathroom
eat
touch
surfac
public
place
particular
attent
paid
environment
clean
healthcar
set
daycar
cruis
ship
institut
set
contagi
enter
virus
norovirus
low
inoculum
requir
spread
diseas
stabil
environ
use
bleach
base
clean
necessari
elimin
norovirus
surfac
hospit
patient
noroviru
place
contact
isol
room
clean
chlorin
bleach
ppm
dilut
household
bleach
hand
rub
alcohol
base
hand
sanit
may
reduc
contact
enter
virus
ineffect
norovirus
handwash
soap
water
recommend
high
infant
morbid
associ
rotavirus
vaccin
develop
rotaviru
vaccin
administ
infant
without
contraind
live
quadrival
rotaviru
vaccin
rotashieldwyeth
initi
licens
unit
state
though
effect
postmarket
surveil
indic
increas
incid
intussuscept
day
vaccin
administr
vaccin
remov
market
replac
rotateq
merck
rotarix
live
oral
reassort
rotateq
virus
rotarix
strain
vaccin
rotateq
vaccin
given
three
dose
month
age
achiev
reduct
sever
rge
sever
ge
first
year
reduct
hospit
rotarix
two
dose
vaccin
given
oral
drop
month
protect
sever
diseas
reduct
hospit
two
season
vaccin
nd
burnett
et
al
nd
tate
parashar
adenovirus
also
often
resist
common
disinfect
may
remain
infecti
prolong
period
medic
instrument
surfac
